Saitama Medical University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordschronic myeloid leukemia・tyrosine kinase inhibitors・dasatinib pleural effusion・WT1 peptide vaccine・acute myeloid leukemia・BCR-ABL T315I detection

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide
• Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects
• Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial
• Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.

• Official profile